Transmembrane Potentials & Characters Immune & Tumor Cell

1. Auflage 2019
ISBN: 978-0-367-24539-9
Verlag: Taylor & Francis Ltd

Buch, Englisch, 176 Seiten, Format (B × H): 174 mm x 246 mm, Gewicht: 485 g

Reihe: Routledge Revivals

First Published in 1979, this book offers a full, comprehensive guide into the potential application of immune and tumor cells. Carefully compiled and filled with a vast repertoire of notes, diagrams, and references this book serves as a useful reference for students of oncology, and other practitioners in their respective fields.

Autoren/Hrsg.

Niemtzow, Richard C.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung

Inhaltsverzeichnis

1. The Electrical Properties of Cells. 2. Use of Fluorescence as a Voltage Indicator in Mononuclear Cells. 3. Lymphocytes and the Immune Response. 4. The Role of Mononuclear and Malignant Cells. 5. Morphology of Mononuclear and Malignant Cells. 6. Transmembrane Potentials of Human Lymphocytes. 7. Membrane Properties of Peritoneal Macrophage. 8. Neuroblastoma: Maturation and Differentiation. 9. Unified Theory on the Basic Mechanism of Normal Mitotic Control and Oncogenesis. 10. Measurement of Transmembrane Potential in the Study of Systemic Disease. Index.

Über Autor(innen)

Richard C. Niemtzow, M.D., Ph.D., did his undergraduate work at Emory University, Atlanta, Georgia and Goddard College, Plainfield, Vermont, where he received a Bachelor of Arts degree. He obtained his M.D. degree at the Faculty of Medicine of Montpellier University, Montpellier, France at the end of 1977. Dr. Niemtzow’s research interests were fostered and developed at the Department of Chemotherapy and Immunotherapy under the direction of Dr. Bernard Serrou and at the National Institute of Biomechanics under the direction of Professor Pierre Rabischong while completing his training in France. Dr. Niemtzow completed his residency in radiation oncology at the University of Texas Medical Branch, Galveston, Texas, in 1981. During his residency, he published numerous papers and a book chapter dealing with transmembrane potentials of mononuclear cells. He was the recipient of several grants dealing with this research and helped organize an International Symposium on the Fundamental Mechanisms in Human Cancer Immunology at Galveston, Texas. In 1981, Dr. Niemtzow served as a radiation oncologist at David Grant USAF Medical Center, Travis AFB, California. In April 1983, he was transferred to Malcolm Grow USAF Medical Center, Andrews AFB, Maryland as chief clinical investigator to run a FDAapproved clinical trial dealing with cancer therapy. He is currently continuing development in new cancer therapeutic modalities and is also practicing radiation oncology at Malcolm Grow USAF Medical Center where he is a staff physician in the United States Air Force. Dr. Niemtzow received his Ph.D. degree in Biological Sciences from Pacific Western University, California, in February 1985.